维普中文期刊产品整合服务
173篇 您的检索式:作者名="Ganly"
    题名 作者 年代 出处 被引量
1Thyroid cancer: Surgery for the pri- mary tumor 显示文摘Nixon IJ Ganly I Shah JP 2013Oral 0ncol2013,49,7:1
2A controlled trial of in tratumoral ONYX-015,a selectively replicating adenovirus,in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer显示文摘KhuriFR NemunaitisJ Ganly I 0,,08:1
3Selective replication and oncolysis in p53 mutant tumors with ONYX-015,an E1B-55kD genedeleted adenovirus,in patients with advanced head and neck cancer:a phase Ⅱ trial显示文摘Nemunaitis J Ganly I Khuri F 2000Cancer Res2000,1560,22:1
4A controlled trial of intratumral ONYX-015,a selectively-replicating adenovirus,incombination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer显示文摘Khuri FR Nemunaitis J Ganly I 2000Nature Medicine2000,6,8:1
5Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx显示文摘Ganly I Patel SG Matsuo J 2006Arch Otolaryngol Head Neck Surg2006,132,1:1
6Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy 显示文摘Nixon IJ Ganly I Patel SG 2012Surgery2012,151,4:1
7Thyroid lobectomy for treatment of well differentiated intrathyroid malignancy显示文摘Nixon IJ Ganly I Patel SG 2012Surgery2012,151,4:1
8A controlled trial of intratumoral ONYX-015, a selective- replicating adenovirus in combination cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer 显示文摘Khuri FR Nemunaitis J Ganly I 2000Nat Med2000,6,8:1
9Long‐term regional control in the observed neck following definitive chemoradiation for node‐positive oropharyngeal squamous cell cancer显示文摘Anuj Goenka Luc G.T. Morris Shyam S. Rao Suzanne L. Wolden Richard J. Wong Dennis H. Kraus Nisha Ohri Jeremy Setton Benjamin H. Lok Nadeem Riaz Borys R. Mychalczak Heiko Schoder Ian Ganly Jatin P. Shah David G. Pfister Michael J. Zelefsky Nancy Y. Lee 2013Int. J. Cancer2013,,:1
10Productive replication of human adenoviruses in mouse epidermal cells显示文摘 Mautner V Balmain A 2000Virol2000,74,:1
11Phase Ⅱ trialof intratumoral administration of ONYX-015,a replication selective adenovirus,in patients with refractory head and neck cancer显示文摘NemunaitisJ KhuriF Ganly I etal 2001J Clin Oncol2001,19,2:1
12Complications of craniofacial resection for malignant tumors of the skull base : report of an International Collaborative Study 显示文摘Ganly I Patel SG Singh B 2005Head Neck2005,27,6:1
13Disease-related death in patients who were considered free of macroscopic disease after initial treatment of well-differentiated thyroid carcinoma显示文摘Nixon IJ Ganly I Palmer FL 2011Thyroid2011,21,5:1
14A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer显示文摘Khuri F Nemunaitis J Ganly I 2000Nat Med2000,6,8:1
15A phase Ⅱ trial of ONYX-015,a selectively replcating adenovirus,in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer显示文摘Kirn H Khuri F Ganly Ⅰ 1999J Clin Oncol1999,18,:1
16A controlled trial of intra-tumoral ONYX -015 ,a selectively replicating adenovirus,in com-bination with cisplatin and 5 - fluorouracil in patients with recur-rent head and neck cancer显示文摘Khuri FR Nemunaitis J Ganly I 2000Nat Med2000,6,8:1
17Phacoemulsification using the burst mode显示文摘Badoza D Fernandez Mendy J Ganly M 2003J Cataract Refract Surg2003,29,:1
18Craniofacial resection for malignant paranasal sinus tumors : report of an intemational collaborative study显示文摘Ganly I Patel SG Singh B 2005Head Neck2005,27,6:1
19Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy 显示文摘Ganly I Ricarte Filho J Eng S 2013J C|in Endocrinol Metab2013,98,5:1
20Observation of clinically negative central compartment lymph nodes in papillary thyroid carcinoma 显示文摘Nixon I J Ganly I Patel S G 2013Surgery2013,154,6:1
返回顶部 每页显示:
共9页 首页 上一页 第1页 下一页 末页 /9 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费